Patent ID: 9138477
Filing Date: 2015-09-22
Classification: A61K,A61P

Abstract:
1. A method of treatment of breast cancer, the method comprising steps of: (a) providing 4,17β-dihydroxyandrost-4-ene-3-one, a salt thereof, or an ester thereof in an amount effective for such treatment; and (b) administering to females in need of such treatment the effective amount of 4,17β-dihydroxyandrost-4-ene-3-one, a salt thereof, or an ester thereof, wherein 4,17β-dihydroxyandrost-4-ene-3-one, a salt thereof, or an ester thereof is an androgen receptor specific compound that binds to an androgen receptor, and wherein 4,17β-dihydroxyandrost-4-ene-3-one, a salt thereof, or an ester thereof elicits anabolic/apoptotic properties rather than androgenic properties.